AIM AIM ImmunoTech, Inc.: Year-over-year earnings per share growth for the last twelve months
The strategic goal of AIM ImmunoTech (AIM) is the monetization of Ampligen as an exclusive treatment for viral pathologies to generate a stable rent. This quarterly earnings per share chart visualizes progress toward this objective, where the 93.70 level indicates the parameter's status. Barriers remain the high cost of the drug due to a lack of analogs and risks associated with R&D expenditures for new RNA-based medicines.
Summary analytical data breakdowns for AIM ImmunoTech, Inc. (AIM)
- share price and consensus valuation forecast:
- company stock capitalization data:
- book capitalization data:
- debt and solvency information:
Total Debt to Capital AIM ImmunoTech|AIM - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity AIM ImmunoTech|AIM - Company Total Debt|Debt to Book Value AIM ImmunoTech|AIM - Company Long-Term Loans and Borrowings|Company Short-Term Debts AIM ImmunoTech|Quick Liquidity aimimmuno.com
- earnings and valuation multiples indicators:
AIM - Net Income|Expected Profit AIM ImmunoTech|AIM - Price to Earnings Ratio|Projected Price to Earnings AIM ImmunoTech Inc.|AIM - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization AIM ImmunoTech|AIM - Operating profit before amortization|Earnings per share for the last twelve months AIM ImmunoTech|AIM - Net earnings per one share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months aimimmuno.com|AIM - Net earnings per one share growth for the current year|Earnings growth forecast for next year AIM ImmunoTech
Basic company analysis:AIM ImmunoTech Inc., AIM
A daily calculation of quarterly net income per share growth allows for an audit of capital efficiency and the business's recovery potential, warning investors against purchasing an asset during the first wave of growth without verifying its margin of safety. Analyzing the volatility of the quarterly EPS indicates that high fixed R&D costs for AIM ImmunoTech immunomodulator trials increase unit costs, confirming the risks of a secondary drawdown.
Who AIM ImmunoTech competes with
ARGX (argenx) - Year-over-year net earnings per share growth for the last 12 months|BioNTech Inc. (BNTX) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months ABIVAX|Year-over-year earnings per share growth for the last 12 months ADMA (ADMA Corp)|Quarterly EPS earnings growth PTGX|IMVT - Earnings per share growth in annualized terms for the last twelve months|Quarterly EPS earnings growth KNSA (Kiniksa)|Quarterly EPS earnings growth Grifols SA GRFS|Adaptive Biotechnologies Corp - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Celldex Corp CLDX|Aurinia Pharmaceuticals (AUPH) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months biocryst.com|Year-over-year net earnings per share growth for the last 12 months VERA|DNTH: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth PHVS|Year-over-year net earnings per share change for the last twelve months AbCellera Bio|Year-over-year earnings per share growth for the last twelve months Tourmaline Bio, Inc. TRML|PGEN - Year-over-year net earnings per share growth for the last 12 months|PHAR - Year-over-year earnings per share growth for the last twelve months|Nektar Therapeutics Inc (NKTR) - Year-over-year net earnings per share growth for the last 12 months|UPB (Upstream Bio Corp) - Year-over-year net earnings per share growth for the last 12 months|Zenas Corp (ZBIO) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Immunome, Inc.|Year-over-year earnings per share growth for the last 12 months GOSS (gossamerbio.com)|Year-over-year earnings per share growth for the last twelve months KalVista Pharmaceuticals, Inc. (KALV)|SEPN - Earnings per share growth in annualized terms for the last twelve months|Pieris Pharmaceuticals Inc - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months SVRA (Savara Pharma)|Rigel Pharmaceuticals - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months anaptysbio.com|ATXS: Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months enGene Holdings Inc|RAPT (RAPT Therapeutics) - Quarterly EPS earnings growth|JBIO: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth ACRS|Quarterly EPS earnings growth kyvernatx.com (KYTX)|Quarterly EPS earnings growth TLSA (Tiziana Life Sciences Ltd)|Year-over-year net earnings per share change for the last twelve months Cabaletta Bio Inc. (CABA)|VTYX - Year-over-year earnings per share growth for the last twelve months|Theratechnologies, Inc (THTX) - Year-over-year net earnings per share growth for the last 12 months|Avalo Therapeutics, Inc (AVTX) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months ELDN (eledon.com)|AGEN (Agenus Inc.) - Quarterly EPS earnings growth|CLYM: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth ZURA|Quarterly EPS earnings growth aTyr Pharmaceuticals (ATYR)|Year-over-year earnings per share growth for the last twelve months Adagene Inc. ADAG|Year-over-year earnings per one share growth for the last 12 months IMA|STTK - Year-over-year earnings per share growth for the last twelve months|Equillium, Inc. (EQ) - Year-over-year net earnings per share growth for the last 12 months|CNTB: Quarterly EPS earnings growth|Immunic (IMUX) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months ATRA|IFRX: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth XFOR|Year-over-year net earnings per share change for the last twelve months adicetbio.com|Year-over-year earnings per share growth for the last twelve months Celularity CELU|INMB - Year-over-year net earnings per share growth for the last 12 months|BRNS - Year-over-year earnings per share growth for the last twelve months|kezarlifesciences.com (KZR) - Year-over-year net earnings per share growth for the last 12 months|SABS (SAB Biotherapeutics, Inc.) - Year-over-year net earnings per share growth for the last 12 months|Akari Therapeutics PLC (AKTX) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Enlivex Therapeutics Ltd|Year-over-year earnings per share growth for the last 12 months QTTB (Q32 Bio Corp)|Quarterly EPS earnings growth GOVX|EDSA - Earnings per share growth in annualized terms for the last twelve months|Quarterly EPS earnings growth IBIO (iBio)|Quarterly EPS earnings growth Carisma Therapeutics Inc CARM|XTL Biopharmaceuticals, Ltd. - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Bolt Biotherapeutics BOLT|hcwbiologics.com (HCWB) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months Aptevo Therapeutics Inc.|Year-over-year net earnings per share growth for the last 12 months ADTX|GRI: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth XRTX|Year-over-year net earnings per share change for the last twelve months Vyome Therapeutics|Year-over-year earnings per share growth for the last twelve months Revelation Biosciences REVB|INDP - Year-over-year net earnings per share growth for the last 12 months|SCNI - Year-over-year earnings per share growth for the last twelve months|CalciMedica, Inc. (CALI) - Year-over-year net earnings per share growth for the last 12 months|AFMD (affimed.com) - Year-over-year net earnings per share growth for the last 12 months|Allakos (ALLK) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months HOOKIPA Pharma, Inc.|Year-over-year earnings per share growth for the last 12 months IGMS (IGM Bio)|Year-over-year earnings per share growth for the last twelve months iTeos Therapeutics, Inc. (ITOS)|OCEA - Earnings per share growth in annualized terms for the last twelve months|TC BioPharm (Holdings) PLC - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months THRD (Third Harmonic Bio Inc)
